Repligen
(NASDAQ:RGEN)
$157.06
-3.92[-2.44%]
At close: Apr 18
$157.06
0[0.00%]
After Hours: 4:06PM EDT
Q1 2024 Earnings in 13 days from now on Wed May 1st, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Repligen Stock (NASDAQ:RGEN), Quotes and News Summary

Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.

Open$154.590
Close$157.060
Volume / Avg.759.238K / 539.410K
Day Range152.190 - 159.350
52 Wk Range110.450 - 211.130
Market Cap$8.770B
P/E Ratio217.446
Dividend Yield-
ExchangeNASDAQ
RSI
25
Short Interest
10%
Days to Cover13.2

Recent News

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.
Avi Kapoor
What's Going On With Life Science-Focused Repligen Stock Today?
Repligen posts Q4 2023 results. CEO Tony Hunt highlights order strength in Filtration and Analytics. Positive momentum in new modalities; 2024 revenue forecast: $620-$650 million.
Vandana Singh
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
Avi Kapoor
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
4
Nov 23
1
Dec 23
2
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Repligen Corp.
Sector
Health Care
Industry
Life Sciences Tools & Services
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioproces...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RGEN
MEDP

FAQ

Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ: RGEN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Repligen's (RGEN) competitors?

A

Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).

Q

What is the target price for Repligen (RGEN) stock?

A

The latest price target for Repligen (NASDAQ: RGEN) was reported by Stifel on Thursday, February 22, 2024. The analyst firm set a price target for 207.00 expecting RGEN to rise to within 12 months (a possible 31.80% upside). 19 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $157.06 last updated April 18, 2024 at 4:06 PM EDT.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch